There’s a lot to be optimistic about in the Consumer Goods sector as 3 analysts just weighed in on Five Below (FIVE – Research Report), Celsius Holdings (CELH – Research Report) and CVS Health (CVS – Research Report) with bullish sentiments.
Five Below (FIVE)
In a report released today, Bradley Thomas from KeyBanc maintained a Buy rating on Five Below, with a price target of $190.00. The company’s shares closed last Friday at $138.56.
According to TipRanks.com, Thomas is a 5-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Five Below with a $166.79 average price target, implying a 23.4% upside from current levels. In a report issued on July 25, J.P. Morgan also maintained a Buy rating on the stock with a $165.00 price target.
Celsius Holdings (CELH)
Jefferies analyst Kevin Grundy maintained a Buy rating on Celsius Holdings yesterday and set a price target of $125.00. The company’s shares closed last Friday at $98.62, close to its 52-week high of $110.22.
According to TipRanks.com, Grundy is a 4-star analyst with an average return of
Celsius Holdings has an analyst consensus of Strong Buy, with a price target consensus of $102.63, implying a -0.8% downside from current levels. In a report issued on August 2, B.Riley Financial also maintained a Buy rating on the stock with a $112.00 price target.
CVS Health (CVS)
Credit Suisse analyst Jonathan Yong maintained a Buy rating on CVS Health today and set a price target of $117.00. The company’s shares closed last Friday at $102.26.
According to TipRanks.com, Yong is ranked #6326 out of 7991 analysts.
Currently, the analyst consensus on CVS Health is a Moderate Buy with an average price target of $118.92, representing a 17.2% upside. In a report issued on August 3, J.P. Morgan also maintained a Buy rating on the stock with a $130.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on FIVE:
- Telephone & Data Systems (TDS) Receives a Buy from Raymond James
- Jefferies Keeps Their Buy Rating on Leslie’s (LESL)
- Analysts Have Conflicting Sentiments on These Healthcare Companies: ICU Medical (ICUI), Twist Bioscience (TWST) and Alignment Healthcare (ALHC)
- Credit Suisse Reaffirms Their Hold Rating on TELUS International (CDA) (TIXT)
- Credit Suisse Keeps Their Hold Rating on TripAdvisor (TRIP)